Revolutionary hemostatic gel for veterinary surgeons now available through Covetrus, MWI Animal Health, and Patterson Veterinary Supply

兽医用革命性止血凝胶现已通过Covetrus、MWI Animal Health和Patterson veterinary Supply提供

NEW YORK, April 19, 2024 /PRNewswire/ -- Cresilon Inc. ('Cresilon'), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced it has entered into distribution agreements for its revolutionary hemostatic gel, VETIGEL®, to be sold directly to veterinary surgeons through several of the leading animal health and veterinary product suppliers in the U.S., including Covetrus, MWI Animal Health, and Patterson Veterinary Supply..

纽约，2024年4月19日/PRNewswire/--总部位于布鲁克林的专注于止血医疗器械技术的生物技术公司Cresilon Inc.（“Cresilon”）今天宣布，它已经签署了其革命性止血凝胶VETIGEL®的分销协议，该凝胶将通过美国几家领先的动物健康和兽医产品供应商直接出售给兽医，包括Covetrus，MWI animal health和Patterson veterinary Supply。。

Cresilon announces distribution agreements through several of the leading US animal health and veterinary suppliers

Cresilon通过几家美国领先的动物健康和兽医供应商宣布分销协议

A plant-based hemostatic gel that instantly stops and controls bleeding without the need to apply manual pressure, VETIGEL is now available online for U.S. veterinary surgeons through Covetrus, MWI Animal Health, and Patterson Veterinary Supply. The hemostatic agent is ideal for the veterinary treatment of traumatic wounds and both routine and complex surgical procedures, such as dental extractions, liver biopsies, tumor and mass removals, cleft palate repairs, and amputations..

VETIGEL是一种基于植物的止血凝胶，无需手动按压即可立即止血和控制出血，现在可通过Covetrus，MWI Animal Health和Patterson veterinary Supply在线为美国兽医提供。止血剂非常适合兽医治疗创伤性伤口以及常规和复杂的外科手术，如拔牙、肝活检、肿瘤和肿块切除、腭裂修复和截肢。。

'We are excited to partner with many of the leading animal health companies to help more veterinary surgeons easily access a groundbreaking all-natural hemostatic product that reduces blood loss and anesthesia time, resulting in better patient outcomes,' said Matt Lewis, Vice President of Sales at Cresilon.

Cresilon销售副总裁马特·刘易斯（MattLewis）说：“我们很高兴与许多领先的动物健康公司合作，帮助更多的兽医轻松获得开创性的全天然止血产品，减少失血和麻醉时间，从而改善患者预后。”。

'Thousands of veterinary surgeons around the world have used VETIGEL and it has proven to be the fastest, most efficient, and cost-effective hemostatic agent on the market.'.

“全世界成千上万的兽医都在使用VETIGEL，它已被证明是市场上最快，最有效，最具成本效益的止血剂。”。

VETIGEL offers veterinary surgeons a safe and effective way to rapidly stop and control bleeding across a wide range of surgical procedures and medical emergencies. Since the product's debut in 2021, veterinary surgeons across North America, Europe, and Asia have increasingly used the plant-based hemostatic gel to help patients heal and recover faster while helping veterinary clinics and animal hospitals save time, reduce operating costs, and improve patient outcomes.

VETIGEL为兽医提供了一种安全有效的方法，可以在各种外科手术和医疗紧急情况下快速停止和控制出血。自2021年该产品问世以来，北美，欧洲和亚洲的兽医越来越多地使用植物止血凝胶来帮助患者更快地愈合和恢复，同时帮助兽医诊所和动物医院节省时间，降低运营成本，改善患者预后。

To date, VETIGEL has been used in more than 50,000 surgical procedures worldwide..

迄今为止，VETIGEL已在全球50000多个外科手术中使用。。

VETIGEL consists of two plant-based polysaccharides that form an instant mechanical barrier to stop bleeding on contact without manual pressure, preparation, or special storage conditions. In its simplest form, VETIGEL can stop even the most severe, pulsating arterial bleeding within seconds by creating an immediate, near-perfect mechanical sealant.

VETIGEL由两种基于植物的多糖组成，它们形成即时的机械屏障，可以在接触时止血，无需手动压力，制备或特殊储存条件。VETIGEL以其最简单的形式，通过创建一种即时的，近乎完美的机械密封剂，可以在几秒钟内阻止甚至最严重的脉动性动脉出血。

Moreover, the plant-based hemostatic gel's uniqueness also lies in its ability to allow the patient to form their own fibrin patch underneath the gel so that, once removed, the wound underneath heals naturally with partially rebuilt vascular structures..

此外，基于植物的止血凝胶的独特性还在于它能够使患者在凝胶下方形成自己的纤维蛋白贴片，因此，一旦移除，下方的伤口就会自然愈合，并部分重建血管结构。。

The hemostatic agent for veterinary surgeons is supplied in a pre-filled syringe, easy to use, and requires no preparation or special storage conditions. For more information about VETIGEL, visit www.vetigel.com.

兽医用止血剂是在预先填充的注射器中提供的，易于使用，不需要准备或特殊的储存条件。有关VETIGEL的更多信息，请访问www.VETIGEL.com。

About Cresilon

关于Cresilon

Cresilon® is a Brooklyn-based biotechnology company that develops, manufactures, and markets hemostatic medical devices utilizing the company's proprietary hydrogel technology. The company's plant-based technology has revolutionized the current standard by stopping traumatic and surgical bleeds in seconds without the need for manual pressure.

Cresilon®是一家总部位于布鲁克林的生物技术公司，利用该公司专有的水凝胶技术开发、制造和销售止血医疗设备。该公司基于植物的技术彻底改变了当前的标准，在几秒钟内停止了创伤性和手术性出血，而无需手动按压。

The company's current and future product lines target veterinary, human trauma, and human surgical applications. Cresilon's mission is to save lives. For more information about Cresilon, which was recently named to Fast Company's annual list of the World's Most Innovative Companies, ranking No. 1 in the medical devices category, visit www.cresilon.com..

该公司目前和未来的产品线针对兽医、人体创伤和人体外科应用。克雷西隆的使命是拯救生命。有关Cresilon的更多信息，请访问www.Cresilon.com。Cresilon最近被Fast公司列入全球最具创新性公司年度名单，在医疗器械类别中排名第一。。

View original content to download multimedia:https://www.prnewswire.com/news-releases/cresilon-announces-distribution-partnerships-for-vetigel-with-leading-animal-health-and-veterinary-product-suppliers-302121669.html

查看原始内容以下载多媒体：https://www.prnewswire.com/news-releases/cresilon-announces-distribution-partnerships-for-vetigel-with-leading-animal-health-and-veterinary-product-suppliers-302121669.html

SOURCE Cresilon

来源Cresilon